CHEBI:28424 - α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer ChEBI ID CHEBI:28424 ChEBI ASCII Name alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer Definition A sialodiosylceramide consisting of the tetrasaccharide α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc attached to the primary hydroxy function of ceramide. Stars This entity has been manually annotated by the ChEBI Team. Submitter Pablo Porras Millan Secondary ChEBI IDs CHEBI:27558, CHEBI:7536, CHEBI:21151, CHEBI:5211, CHEBI:71174, CHEBI:21918 Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C53H90N3O29R Net Charge 0 Average Mass (excl. R groups) 1233.287 Monoisotopic Mass (excl. R groups) 1232.56600 SMILES [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H](CO)[C@@H](O)[C@]1([H])O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H](NC([*])=O)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@@H]2CO)[C@@H]1O)C(O)=O)C(O)=O)[C@H](O)[C@H](O)CO Metabolite of Species Details Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed Homo sapiens (NCBI:txid9606) See: DOI Roles Classification Biological Role(s): human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). View more via ChEBI Ontology ChEBI Ontology Outgoing α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28424) has part α-Neup5Ac-(2→8)-α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-β-D-Glcp-yl group (CHEBI:142532) α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28424) has role human metabolite (CHEBI:77746) α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28424) has role mouse metabolite (CHEBI:75771) α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28424) is a sialodiosylceramide (CHEBI:36544) α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28424) is conjugate acid of ganglioside GD3(2−) (CHEBI:78436) Incoming ganglioside GD3(2−) (CHEBI:78436) is conjugate base of α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:28424) IUPAC Name (2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→8)-5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranoside Synonyms Sources (Gal)1 (Glc)1 (Neu5Ac)2 (Cer)1 KEGG GLYCAN (Neu5Ac)GD3 ChEBI α-N-acetylneuraminosyl-(2→8)-α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide ChEBI α-N-acetylneuraminosyl-(2→8)-α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramides ChEBI alpha-N-Acetylneuraminyl-2,8-alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-glucosyl-1,1'-ceramide KEGG COMPOUND α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer ChEBI CD60a KEGG GLYCAN disialoganglioside GD3 ChEBI Ganglioside GD3 ChEBI GD3 KEGG COMPOUND GD3 ganglioside ChEBI Neu5Acα2→8Neu5Acα2→3Galβ1→4Glcβ1→1Cer ChEBI NeuAc(α2-8)NeuAc(α2-3)Gal(β1-4)Glc(β1-1)Cer ChEBI NeuAc-alpha2->8NeuAc-alpha2->3Gal-beta1->4Glc-beta1->1'Cer KEGG COMPOUND NeuAc-alpha2->8NeuAc2->3Gal-beta1->4Glc-beta1->1'Cer KEGG COMPOUND NeuAc-alpha2->8NeuAc2->3LacCer KEGG COMPOUND NeuAc2-GD3 ChEBI NeuAcα2-8NeuAcα2-3Galβ1-4Glcβ1-1'Cer ChEBI Manual Xrefs Databases C06133 KEGG COMPOUND G00113 KEGG GLYCAN View more database links Citations Last Modified 07 December 2018